A Study of Oral Oteseconazole (VT-1161) for the Treatment of Patients With Recurrent Vaginal Candidiasis (Yeast Infection)

NCT03561701 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

425

Enrollment

INDUSTRY

Sponsor class

Conditions

Recurrent Vulvovaginal Candidiasis

Interventions

DRUG: Oteseconazole (VT-1161)
DRUG: Placebo

Sponsor

Mycovia Pharmaceuticals Inc.